Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Hormones Medicine & Life Sciences
Kidney Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1998 2023

Research Output 1986 2017

Renal Cell Carcinoma
Interleukin-2
Muscles
Neoplasms
Sarcopenia
2 Citations

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2

Stenehjem, D. D., Toole, M., Merriman, J., Parikh, K., Daignault, S., Scarlett, S., Esper, P., Skinner, K., Udager, A., Tantravahi, S. K., Gill, D., Straubhar, A. M., Agarwal, A. M., Grossmann, K. F., Samlowski, W. E., Redman, B., Agarwal, N. & Alva, A. Aug 1 2016 In : Cancer Immunology and Immunotherapy. 65, 8, p. 941-949 9 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Interleukin-2
Disease-Free Survival
Immunotherapy
Cell Survival
10 Citations

Safety and efficacy of nivolumab in patients with metastatic renal cell carcinoma treated beyond progression

George, S., Motzer, R. J., Hammers, H. J., Redman, B. G., Kuzel, T. M., Tykodi, S. S., Plimack, E. R., Jiang, J., Waxman, I. M. & Rini, B. I. Sep 1 2016 In : JAMA Oncology. 2, 9, p. 1179-1186 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Safety
Response Evaluation Criteria in Solid Tumors
Incidence
Disease-Free Survival
1 Citations

Use of preoperative PET/CT staging in sentinel lymph node-positive melanoma

Scheier, B. Y., Lao, C. D., Kidwell, K. M. & Redman, B. G. Jan 1 2016 In : JAMA Oncology. 2, 1, p. 136-137 2 p.

Research output: Contribution to journalLetter

Melanoma
Lymph Nodes
6 Citations

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

Kudchadkar, R., Ernst, S., Chmielowski, B., Redman, B. G., Steinberg, J., Keating, A., Jie, F., Chen, C., Gonzalez, R. & Weber, J. May 1 2015 In : Cancer Medicine. 4, 5, p. 643-650 8 p.

Research output: Contribution to journalArticle

Bromides
Melanoma
Survival Rate
Disease-Free Survival
Advisory Committees